Drugging the Undruggable
Dhirendra Simanshu
National Cancer Institute's RAS Initiative at Frederick National Laboratory for Cancer Research
Published June 29, 2026
Before fans packed stadiums for the 2026 World Cup, another crowd rose to its feet for a soccer ball of a different sort. But the standing ovation wasn't for a goal. Instead, it was for a drug aimed at KRAS, a soccer-ball-shaped protein whose mutations drive some of the most lethal and challenging cancers, showed an encouraging response in one-third of patients with advanced pancreatic cancer and nearly doubled median overall survival from 6.6 to 13.2 months.
For researchers like Dhirendra Simanshu, the results marked a long-sought clinical validation, but they also underscored the need …
Find out More »